Bourne Lent Asset Management Inc Johnson & Johnson Transaction History

Bourne Lent Asset Management Inc

$233 Million
Q1 2025

A detailed history of Bourne Lent Asset Management Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Bourne Lent Asset Management Inc holds 14,251 shares of JNJ stock, worth $2.18 Million. This represents 1.01% of its overall portfolio holdings.

Number of Shares

14,251

Previous 14,366 0.8%

Holding current value

$2.18 Million

Previous $2.08 Million 13.77%

% of portfolio

1.01%

Previous 0.79%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 14, 2025	SELL	$142.06 - $167.7 $16,336 - $19,285	-115 Reduced 0.8%	14,251 $2.36 Million
Q4 2024 Jan 17, 2025	BUY	$143.34 - $165.86 $28,668 - $33,172	200 Added 1.41%	14,366 $2.08 Million
Q3 2024 Oct 15, 2024	BUY	$145.48 - $167.38 $7,273 - $8,369	50 Added 0.35%	14,166 $2.3 Million
Q2 2024 Aug 01, 2024	SELL	$144.38 - $157.78 $32,485 - $35,500	-225 Reduced 1.57%	14,116 $2.06 Million
Q2 2023 Jul 17, 2023	SELL	$154.35 - $166.11 $19,293 - $20,763	-125 Reduced 0.86%	14,341 $2.37 Million
Q4 2022 Jan 23, 2023	SELL	$160.2 - $179.79 $166,608 - $186,981	-1,040 Reduced 6.71%	14,466 $0
Q2 2022 Jul 27, 2022	SELL	$168.19 - $186.01 $33,638 - $37,202	-200 Reduced 1.27%	15,506 $2.75 Million
Q1 2022 Apr 26, 2022	SELL	$158.14 - $179.59 $7,906 - $8,979	-50 Reduced 0.32%	15,706 $2.78 Million
Q3 2021 Oct 20, 2021	SELL	$161.5 - $179.47 $16,150 - $17,947	-100 Reduced 0.63%	15,756 $2.55 Million
Q1 2021 Apr 23, 2021	BUY	$153.07 - $170.48 $9,184 - $10,228	60 Added 0.38%	15,856 $2.61 Million
Q4 2020 Jan 27, 2021	SELL	$137.11 - $157.38 $43,875 - $50,361	-320 Reduced 1.99%	15,796 $2.49 Million
Q1 2020 Apr 17, 2020	SELL	$111.14 - $153.99 $59,459 - $82,384	-535 Reduced 3.21%	16,116 $2.11 Million
Q3 2019 Oct 24, 2019	SELL	$126.95 - $142.14 $6,347 - $7,106	-50 Reduced 0.3%	16,651 $2.15 Million
Q4 2018 Jan 28, 2019	BUY	$122.84 - $147.84 $62,034 - $74,659	505 Added 3.12%	16,701 $2.16 Million
Q2 2018 Jul 25, 2018	SELL	$119.4 - $131.76 $41,790 - $46,116	-350 Reduced 2.12%	16,196 $1.97 Million
Q1 2018 Apr 20, 2018	SELL	$125.1 - $148.14 $52,542 - $62,218	-420 Reduced 2.48%	16,546 $2.12 Million
Q4 2017 Feb 06, 2018	BUY	$131.22 - $143.62 $125,971 - $137,875	960 Added 6.0%	16,966 $2.37 Million
Q3 2017 Oct 16, 2017	BUY	$129.47 - $135.38 $2.07 Million - $2.17 Million	16,006	16,006 $2.08 Million

Others Institutions Holding JNJ

# of Institutions

4,652

Shares Held

1.73B

Call Options Held

25M

Put Options Held

15.1M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $400B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bourne Lent Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bourne Lent Asset Management Inc with notifications on news.

Account

Bourne Lent Asset Management Inc Johnson & Johnson Transaction History